References
- 1. Enger SM, Ross RK, Henderson B, Bernstein L. Breast-feeding history, pregnancy experience and risk of breast cancer. Br J Cancer 1997;76:118-123.
- 2. Rosa-Rosa JM, Pita G, Urioste M, Llort G, Brunet J, Lázaro C, Blanco I, Ramón Y, Cajal T, Díez O, de la Hoya M, Caldés T, Tejada MI, González-Neira A, Benítez J. Genome-wide linkage scan reveals three putative breast-cancer susceptibility loci. Am J Hum Genet 2009; 84:115-122.
- 3. Saadat M, Ansari-Lari M. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res Treat 2009;115:137-144.
- 4. Saadat M. Offspring sex ratio at birth and maternal breast cancer risk: A case-control study and meta-analysis of literature. EXCLI Journal 2010;9:76-81.
- 5. Collaborative group on Hormonal Factors in Breast cancer. Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95067 women without the disease. Br J Cancer 2002; 87:1234-1245.
- 6. Ueji M, Ueno E. Osei-Hirayama D, Saito T, Takahashi H, Kano K. Risk factors for breast cancer among Japanese women: a case-control study in Ibaraki, Japan. Breast Cancer 1998;5: 351-358.
- 7. Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M, Tsugane S. Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jap J Clil Oncol 2006;36:387-394.
- 8. Zhang X, Condon JR, Rumbold AR, Cunningham J, Roder DM. Estimating cancer incidence in Indigenous Australians. Aust N Z J Public Health 2011;35:477-485.
- 9. Rollison DE, Brownson RC, Hathcock HL, Newschaffer CJ. Case-control study of tobacco smoke exposure and breast cancer risk in Delaware. BMC Cancer 2008;8:157.
- 10. Cotterchio M, Mirea L, Ozcelik H, Kreiger N. Active cigarette smoking, variants in carcinogen metabolism genes and breast cancer risk among pre- and post-menopausal women in Ontario, Canada. Breast J 2014;20:468-480.
- 11. Podkowa N, Komasińska P, Roszak M, Gryczka R, Grodecka-Gazdecka S, Łacka K. Health behaviours among women diagnosed with breast tumours. Pol Merkur Lekarski 2014;37:153-158.
- 12. Ewertz M, Gillanders S, Meyer L, Zedeler K. Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer. Int J Cancer 1991; 49:526-530.
- 13. Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW Jr. Cigarette smoking and risk of fatal breast cancer. Am J Epidemiol 1994;139:1001–1007.
- 14. Manjer J, Andersson I, Berglund G, Bondesson L, Garne JP, Janzon L, Malina J, Matson S. Survival of women with breast cancer in relation to smoking. Eur J Surgery 2000;166:852-858.
- 15. Holmes MD, Murin S, Chen WY, Kroenke CH, Spiegelman D, Colditz GA. Smoking and survival after breast cancer diagnosis. Int J Cancer 2007;120:2672-2677.
- 16. Mohamadynejad P, Saadat M. Genetic polymorphisms of XRCC1 (at codons 194 and 399) in Shiraz population (Fars province, southern Iran). Mol Biol Rep 2008;35:669-672.
- 17. Rafiee L, Saadat I, Saadat M. Glutathione S-transferase genetic polymorphisms (GSTM1, GSTT1 and GSTO2) in three Iranian populations. Mol Biol Rep 2010;37:155-158.
- 18. Teare MD, Wallance SA, Harris M, Howell A, Birch JM. Cancer experience in the relatives of an unselected series of breast cancer patients. Br J Cancer 1994;70:102-111.
- 19. Osanai M, Lee GH. Nicotine-mediated suppression of the retinoic acid metabolizing enzyme CYP26A1 limits the oncogenic potential of breast cancer. Cancer Sci 2011;102:1158-1163.
- 20. Petrakis NL, Grurnke LD, Beelen TC, Castagnori N Jr, Craig JC. Nicotine in breast fluid of nonlactating women. Science 1978;199:303-305.
- 21. Li D, Wang M, Firozi PF, Chang P, Zhang W, Baer-Dubowska W, Moorthy B, Vulimiri SV, Goth-Goldstein R, Weyand EH, DiGiovanni J. Characterization of a major aromatic DNA adduct detected in human breast tissue. Environ Mol Mutagen 2002;39: 193-200.
- 22. Nakajima M, Kwon JT, Tanaka N. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans. Clin Pharmacol Ther 2001;69:72-78.
- 23. Tyndale RF, Sellers EM. Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior. Ther Drug Monit 2002;24:163-171.
- 24. Sergentanis TN, Economopoulos KP. GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2010;121:195-202.
- 25. Qiu LX, Yuan H, Yu KD, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC. Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects. Breast Cancer Res Treat 2010;121:703-708.
- 26. Justenhoven C, Pentimalli D, Rabstein S, Harth V, Lotz A, Pesch B, Brüning T, Dörk T, Schürmann P, Bogdanova N, Park-Simon TW, Couch FJ, Olson JE, Fasching PA, Beckmann MW, Häberle L, Ekici A, Hall P, Czene K, Liu J, Li J, Baisch C, Hamann U, Ko YD, Brauch H. CYP2B6*6 is associated with increased breast cancer risk. Int J Cancer 2014;134:426-630.
- 27. Tian Z, Li YL, Zhao L, Zhang CL. Role of CYP1A2 1F polymorphism in cancer risk: evidence from a meta-analysis of 46 case-control studies. Gene 2013;524:168-174.